VitroScan is dedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients.
VitroScan has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in November 2024.
VitroScan's investors include Biotech Booster.
VitroScan is headquartered in Leiden, The Netherlands.
VitroScan is dedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients.
VitroScan is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VitroScan — Funding & Investors." VCBacked, November 25, 2024, https://www.vcbacked.co/company/vitroscan. Accessed September 30, 2026.
VCBacked. (2024). VitroScan — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/vitroscan
{{cite web |title=VitroScan — Funding & Investors |url=https://www.vcbacked.co/company/vitroscan |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated